Evidence map›Paper›PMID 28130334›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2017

Blockade of CaMKII depresses conduction preferentially in the right ventricular outflow tract and promotes ischemic ventricular fibrillation in the rabbit heart.

Mark Warren, Katie J Sciuto, Tyson G Taylor, Vivek Garg, Natalia S Torres, Junko Shibayama, Kenneth W Spitzer, Alexey V Zaitsev

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Guidelines for experimental models of myocardial ischemia and infarction.American journal of physiology. Heart and circulatory physiology · 2018
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Chronic CaThe Journal of pharmacology and experimental therapeutics · 2021
    Article
  8. Review
  9. Article
  10. Statistical considerations in reporting cardiovascular research.American journal of physiology. Heart and circulatory physiology · 2018
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mark WarrenNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah Mark.Warren@utah.edu.
Katie J SciutoNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah.
Tyson G TaylorNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah.
Vivek GargNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah.
Natalia S TorresNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah.
Junko ShibayamaNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah.
Kenneth W SpitzerNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah.
Alexey V ZaitsevNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah.
University of Utah · US

Funding

TRAINING IN CARDIOVASCULAR RESEARCHT32HL007576 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Stavros George Drakos, Robin M Shaw · 1985 to 2026
$10.6M
Physiology and Biophysics of Cardiac Slo2.1 ChannelsR01HL103877 · NHLBI · UNIVERSITY OF UTAH · PI SANGUINETTI, MICHAEL CRAIG, ZAITSEV, ALEXEY V · 2011 to 2015
$2.1M
NHLBI NIH HHS R01 HL103877NHLBI NIH HHS T32 HL007576
6 · The paper itself

Abstract

Calcium/calmodulin-dependent protein kinase II (CaMKII) regulates the principle ion channels mediating cardiac excitability and conduction, but how this regulation translates to the normal and ischemic heart remains unknown. Diverging results on CaMKII regulation of Na

Indexed as

AnimalsArrhythmias, CardiacBenzenesulfonamidesBenzylaminesCalcium-Calmodulin-Dependent Protein Kinase Type 2Coronary CirculationEnzyme InhibitorsFemaleHeartHeart Conduction SystemIn Vitro TechniquesMaleMembrane PotentialsMyocardial IschemiaMyocytes, CardiacRabbitsBenzenesulfonamidesBenzylaminesCalcium-Calmodulin-Dependent Protein Kinase Type 2Enzyme InhibitorsKN 93Sulfonamidescalcium/calmodulin-dependent protein kinase IIcardiac conductionischemiaright ventricular outflow tractventricular fibrillation

Identifiers

PMID28130334
PMCPMC5407168
OpenAlexW2582675228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.